These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner. Peter K, Gupta A, Nordt T, Bauer S, Runge MS, Bode C. J Cardiovasc Pharmacol; 2003 Aug; 42(2):237-44. PubMed ID: 12883328 [Abstract] [Full Text] [Related]
3. Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide. Hagemeyer CE, Tomic I, Jaminet P, Weirich U, Bassler N, Schwarz M, Runge MS, Bode C, Peter K. Thromb Haemost; 2004 Jul; 92(1):47-53. PubMed ID: 15213844 [Abstract] [Full Text] [Related]
4. Hirudin display on the surface of bacteriophage M13. Zhou Y, Qin H, Xu J, Huang Y, Zhu S. Chin J Biotechnol; 1999 Jul; 15(1):29-35. PubMed ID: 10668132 [Abstract] [Full Text] [Related]
8. Factor X fusion proteins: improved production and use in the release in vitro of biologically active hirudin from an inactive alpha-factor-hirudin fusion protein. Guarna MM, Côté HC, Kwan EM, Rintoul GL, Meyhack B, Heim J, MacGillivray RT, Warren RA, Kilburn DG. Protein Expr Purif; 2000 Nov; 20(2):133-41. PubMed ID: 11049737 [Abstract] [Full Text] [Related]
9. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen. Zhang JL, Gou JJ, Zhang ZY, Jing YX, Zhang L, Guo R, Yan P, Cheng NL, Niu B, Xie J. Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583 [Abstract] [Full Text] [Related]
12. Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase. Hagemeyer CE, Tomic I, Weirich U, Graeber J, Nordt T, Runge MS, Bode C, Peter K. J Thromb Haemost; 2004 May; 2(5):797-803. PubMed ID: 15099287 [Abstract] [Full Text] [Related]
13. A fusion protein with improved thrombolytic effect and low bleeding risk. Wang X, Zhang G, Wang L, Zhang Q, Qin Y, Wu C, Yu A. Thromb Haemost; 2009 Dec; 102(6):1194-203. PubMed ID: 19967151 [Abstract] [Full Text] [Related]
14. Display of functional thrombin inhibitor hirudin on the surface of phage M13. Wirsching F, Opitz T, Dietrich R, Schwienhorst A. Gene; 1997 Dec 19; 204(1-2):177-84. PubMed ID: 9434182 [Abstract] [Full Text] [Related]
15. Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential. Lijnen HR, Wnendt S, Schneider J, Janocha E, Van Hoef B, Collen D, Steffens GJ. Eur J Biochem; 1995 Nov 15; 234(1):350-7. PubMed ID: 8529664 [Abstract] [Full Text] [Related]